Home
Live Updates
Peijia Medical Announces Successful Completion of Patient Enrollment for Pivotal TaurusTrio™ Transcatheter Aortic Regurgitation Clinical Trial : vimarsana.com
Peijia Medical Announces Successful Completion of Patient Enrollment for Pivotal TaurusTrio™ Transcatheter Aortic Regurgitation Clinical Trial
SUZHOU, China, Jan. 29, 2024 /PRNewswire/ -- Peijia Medical Limited (Peijia, (9996.HK)), a leading Chinese domestic player in the high-growth transcatheter
Related Keywords
China ,
Suzhou ,
Jiangsu ,
Peijia ,
Henan ,
Chinese ,
John Kilcoyne ,
Michael Zhang ,
Peijia Medical Limited ,
Jenavalve Technology Inc ,
National Medical Products Administration ,
Aortic Valve Replacement ,
Valve System ,
Aortic Regurgitation ,
Jenavalve Technology ,
Greater China ,
Chief Executive Officer ,
Late Breaking Clinical Trial ,
Cardiovascular Therapeutics ,
Annual Scientific Symposium ,
vimarsana.com © 2020. All Rights Reserved.